Evidence map›Paper›PMID 20961312›Full record

ReviewAnnals of the New York Academy of Sciences2010

Lymphatic system: a vital link between metabolic syndrome and inflammation.

Sanjukta Chakraborty, Scott Zawieja, Wei Wang, David C Zawieja, Mariappan Muthuchamy

Open access · greenAbstract readReview
In one paragraph

Review in Annals of the New York Academy of Sciences, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 79 citations in OpenAlex.

  1. Review
  2. Article
  3. Hypertension: a lymphatic disease?Clinical science (London, England : 1979) · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Detection of Mast Cells in Human Superficial Fascia.International journal of molecular sciences · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. The Role of AIM2 Inflammasome in Knee Osteoarthritis.Journal of inflammation research · 2022
    Review
  15. Role of mesenteric component in Crohn's disease: A friend or foe?World journal of gastrointestinal surgery · 2021
    Review
  16. Review
  17. Regulation of Chylomicron Secretion: Focus on Post-Assembly Mechanisms.Cellular and molecular gastroenterology and hepatology · 2019
    Review
  18. Cardiac lymphatics in health and disease.Nature reviews. Cardiology · 2019
    Review
  19. Mesenteric Lymphatic Vessel Density Is Associated with Disease Behavior and Postoperative Recurrence in Crohn's Disease.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sanjukta ChakrabortyDivision of Lymphatic Biology, Department of Systems Biology and Translational Medicine, Cardiovascular Research Institute, Texas A&M Health Science Center College of Medicine, College Station, Texas 77843, USA.
Scott Zawieja
Wei Wang
David C Zawieja
Mariappan Muthuchamy
Texas A&M Health Science Center · US

Funding

Influences of Lymph Flow on the Lymphatic PumpR01HL070308 · NHLBI · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI ZAWIEJA, DAVID CARL · 2003 to 2010
$2.4M
Molecular Mechanisms of Lymphatic Muscle ContractionR01HL080526 · NHLBI · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI MUTHUCHAMY, MARIAPPAN · 2005 to 2009
$1.7M
Ionic Mechanisms of Stretch-Activation in Muscular LymphaticsR01HL096552 · NHLBI · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI VON DER WEID, PIERRE-YVES, ZAWIEJA, DAVID CARL · 2009 to 2012
$1.7M
Regulatory Mechanisms in Lymphatic Muscle ContractionK02HL086650 · NHLBI · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI MUTHUCHAMY, MARIAPPAN · 2007 to 2011
$502k
NHLBI NIH HHS K02 HL086650NHLBI NIH HHS KO2 HL086650NHLBI NIH HHS R01 HL070308NHLBI NIH HHS R01HL070308NHLBI NIH HHS R01 HL080526NHLBI NIH HHS R01 HL096552
6 · The paper itself

Abstract

Metabolic syndrome is defined by a cluster of different metabolic risk factors that include overall and central obesity, elevated fasting glucose levels, dyslipidemia, hypertension, and intimal atherogenesis. Metabolic syndrome leads to increased risk for the development of type 2 diabetes and cardiovascular disease (e.g., heart disease and stroke). The exacerbated progression of metabolic syndrome to cardiovascular disease has lead to intense study of the physiological ramifications of metabolic syndrome on the blood vasculature. These studies have particularly focused on the signaling and architectural alterations that manifest in hypertension and atherosclerosis. However, despite the overlap of metabolic syndrome pathology with lymphatic function, tangent effects on the lymphatic system have not been extensively documented. In this review, we discuss the current status of metabolic syndrome and provide evidence for, and the remaining challenges in studying, the connections among the lymphatic system, lipid transport, obesity, insulin resistance, and general inflammation.

Indexed as

Adipose TissueAnimalsHumansInflammationLipid MetabolismLymphatic SystemMetabolic SyndromeMiceRatsinflammationlymphatic pumplymphatics and lipid transportmetabolic syndrome

Identifiers

PMID20961312
PMCPMC2965625
OpenAlexW1589775888

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.